XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Vitamin D3 Clinical Trial

Official title:
A Randomized, Multicenter, Double-blinded, Phase III Study of Vitamin D3 in Combination With Oxaliplatin Plus Fluoropyrimidine Versus Oxaliplatin Plus Fluoropyrimidine as First-line Chemotherapy in Previously Untreated Advanced or Metastatic Colorectal Cancer

Status Not yet recruiting

Clinical Trial Summary

The study is a randomized,multicenter, double-blinded,phase III study. To explore the affection of vitamin D3 in combination with oxaliplatin plus fluoropyrimidine versus oxaliplatin plus fluoropyrimidine as first-line chemotherapy in previously untreated advanced or metastatic colorectal cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Vitamin D3

Clinical Trial Details

NCT number	NCT03389659
Study type	Interventional
Source	Tianjin Medical University Cancer Institute and Hospital
Contact	Ting Deng
Phone	+86 15802243063
Email	xymcdengting@126.com
Status	Not yet recruiting
Phase	Phase 3
Start date	February 2018
Completion date	June 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01462058` - The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff	Phase 4
Recruiting	`NCT04036188` - Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis	Early Phase 1
Recruiting	`NCT05450419` - The Role of Vitamin D3 Supplementation in Advanced Cancer Patients With Pain	N/A
Recruiting	`NCT03871322` - The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures	N/A
Completed	`NCT03645109` - Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus	N/A
Recruiting	`NCT03984890` - Vitamin D3 For CGD Patients With BCGosis/Itis	Phase 2/Phase 3